Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 213 - Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
Patents for C07D 213 - Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members (63,273)
12/2012
12/26/2012CN102838536A 3-cyanopyridine derivative and preparation as well as application thereof
12/26/2012CN102838535A Preparation method of nicotinoyl thiourea derivatives
12/26/2012CN102838534A Preparation method of flupirtine maleate
12/26/2012CN102838533A Preparation method of roflumilast and key intermediate of roflumilast
12/26/2012CN102838532A Novel compounds for a treatment of diseases associated with amyloid or amyloid-like proteins
12/26/2012CN102838531A Synthesis method of pyridylacetonitrile
12/26/2012CN102838530A Aloe emodin derivative and preparation method thereof
12/26/2012CN102838529A Synthetic method of pyridinemethanol
12/26/2012CN102838528A Alkylpyridinium dicyanamides and preparation method thereof
12/26/2012CN102838460A Series of skin-whitening (lightening) compounds
12/26/2012CN102838443A Hexafluorenylbenzene derivative and application thereof to organic photoelectric functional material
12/26/2012CN102838442A 9-alkenylfluorene derivatives and application thereof
12/26/2012CN102835398A Method for preparing clopyralid choline aqueous solution and active compound
12/26/2012CN101898999B Method for synthesizing pyridinecarbaldehydes compound with direct oxidization method
12/26/2012CN101857517B Method for preparing fluorobiaryl compound in pure water solution
12/26/2012CN101812093B One-dimensional micron or submicron material of polypyridine platinum complex as well as preparation method and application thereof
12/26/2012CN101768111B Method for preparing 2-chloro-5-fluoropyridine-3-benzoic acid
12/26/2012CN101730703B Benzamide derivatives with anti-proliferative activity, pharmaceutical preparations thereof
12/26/2012CN101676267B N-4-(1-cyan cyclopentyl) phenyl-2-(4-picolyl) amidogen-3-pyridinecarboxamide salt
12/26/2012CN101466678B Substituted 3-cyanopyridines as protein kinase inhibitors
12/26/2012CN101437799B p38 MAP kinase inhibitors
12/25/2012US8338614 e.g. 2-[5-(5-methyl-1,3-diphenyl-1H-pyrazol-4-yl)-1,3,4-oxadiazol-2-yl]-1-phenylpropan-2-amine; neurodegenerative diseases; preventing the formation of insoluble amyloid beta and arresting the production of amyloid beta
12/25/2012US8338612 Process for producing toluidine compound
12/25/2012US8338611 Opioid receptor antagonists
12/25/2012US8338610 Pyridinyl compounds useful as intermediates
12/25/2012US8338602 Quaternary nitrogen heterocyclic compounds for detecting aqueous monosaccharides in physiological fluids
12/25/2012US8338601 Slow release of organoboronic acids in cross-coupling reactions
12/25/2012US8338431 Phosphodiesterase inhibitors
12/25/2012US8338426 Piperazinyl derivatives useful as modulators of the neuropeptide Y2 receptor
12/25/2012US8338412 Inhibitors of P38
12/25/2012US8338362 Methods for controlling SR protein phosphorylation, and antiviral agents whose active ingredients comprise agents that control SR protein activity
12/25/2012US8337569 Polymeric hair dyes
12/20/2012WO2012173073A1 Light emitting element material and light emitting element
12/20/2012WO2012171484A1 Substituted cyanoaniline compounds, preparation and use thereof
12/20/2012WO2012148090A3 Production of diamine having a novel structure containing a terpyridine or phenanthroline functional group and a use therefor
12/20/2012US20120323014 Method for producing alpha-acyloxycarbonyl compound and novel alpha-acyloxycarbonyl compound
12/20/2012US20120322875 4-((phenoxyalkyl)thio)-phenoxyacetic acids and analogs
12/20/2012US20120322836 Pharmaceutical compositions and methods for stabilizing the same
12/20/2012US20120322835 Pharmaceutical compositions and methods for producing low impurity concentrations of the same
12/20/2012US20120322831 Compositions for reducing ab 42 production and their use in treating alzheimer's disease (ad)
12/20/2012US20120322801 Heterocyclic amides as rock inhibitors
12/20/2012US20120322769 Methods of reducing virulence in bacteria
12/19/2012EP2535767A1 Smart window employing organic/metallic hybrid polymer, method for manufacturing smart window, and smart window system
12/19/2012EP2535330A2 Iminopyridine derivative and use thereof
12/19/2012EP2535328A1 Fluoroalkane derivative, gelling agent and gel composition
12/19/2012EP2535327A1 Insecticidal 3-acylaminobenzanilides
12/19/2012CN102834381A Derivatives of pyridoxine for inhibiting HIV integrase
12/19/2012CN102834380A Inhibitors of protein kinases
12/19/2012CN102834368A Method for producing alpha-acyloxycarbonyl compound and novel alpha-acyloxycarbonyl compound
12/19/2012CN102827073A Therapeutically active compositions and application methods thereof
12/19/2012CN102827072A Substituted nitroaniline compound and its application
12/19/2012CN102827071A Compound containing aminobenzonitrile and application thereof
12/19/2012CN102827070A Improved process for synthesizing N-(6-chloro-3-picolyl)-methylamine
12/19/2012CN102827069A Method for preparing two organic compounds by using chlorogenic acid as raw material and application thereof
12/19/2012CN102827034A P-dicyanoaniline-containing compounds and applications thereof
12/19/2012CN102827033A Compound containing o-dicyanoaniline and application thereof
12/19/2012CN102295598B Crystallization method of vitamin B6
12/19/2012CN101973932B Preparation method of bisacodyl
12/19/2012CN101242858B Conjugates having a degradable linkage and polymeric reagents useful in preparing such conjugates
12/18/2012US8334402 Biological buffers with wide buffering ranges
12/18/2012US8334381 Process for the preparation of intermediates useful in the synthesis of imatinib
12/18/2012US8334316 Substituted organosulfur compounds and methods of using thereof
12/18/2012US8334308 Renin inhibitors
12/18/2012US8334290 CETP inhibitors
12/18/2012CA2581835C Process for the preparation of 4-{4-[({[4-chloro-3-(trifluoromethyl)phenyl]amino}carbonyl)amino]phenoxy}-n-methylpyridine-2-carboxamide
12/18/2012CA2536576C Derivatives of hydroxamic acid as metalloproteinase inhibitors
12/18/2012CA2533812C Substituted cycloalkylidene compounds
12/18/2012CA2511214C Asthma and allergic inflammation modulators
12/18/2012CA2504385C Thiadiazine compounds and uses thereof
12/13/2012WO2012170976A2 Compositions and methods for the production of pyrimidine and pyridine compounds with btk inhibitory activity
12/13/2012WO2012170792A1 Atazanavir metabolite derivatives
12/13/2012WO2012170377A1 Process for preparing [(3-hydroxypyridine-2-carbonyl)amino]alkanoic acids, esters and amides
12/13/2012WO2012169571A1 Novel n-(pyridin-2-yl)alkanamide derivative and ship2 inhibitor containing same as an active ingredient
12/13/2012WO2012169555A1 Method for manufacturing oxetane compound, method for manufacturing azolylmethylcyclopentanol compound, and intermediate compound
12/13/2012WO2012168350A1 Pyridin- 2 -amides useful as cb2 agonists
12/13/2012WO2012168226A1 Derivatives of 1-phenyl-2-pyridinyl alkyl alcohols as phosphodiesterase inhibitors
12/13/2012WO2012168162A1 Benzocycloheptene acetic acids
12/13/2012WO2012138254A3 Pharmacologically active 4,4'-biphenylamide derivatives and drugs based thereon
12/13/2012US20120316345 Processes for producing phenyl-6-(1-(phenyl)ureido)nicotinamides)
12/13/2012US20120316341 Fluorination of organic compounds
12/13/2012US20120316204 Compounds and compositions for stabilizing hypoxia inducible factor-2 alpha as a method for treating cancer
12/13/2012US20120316200 Pyridone derivatives
12/13/2012US20120316197 Use of ep4 receptor antagonists in the treatment of il-23 mediated diseases
12/13/2012US20120316195 Aryl-pyridine derivatives as aldosterone synthase inhibitors
12/13/2012US20120316182 Compounds that modulate intracellular calcium
12/13/2012US20120316169 2-aryl-propionamide derivatives useful as bradykinin receptor antagonists and pharmaceutical compositions containing them
12/13/2012US20120316147 Novel pyridine derivatives
12/13/2012US20120316066 Chiral Diacylhydrazine Ligands for Modulating the Expression of Exogenous Genes via an Ecdysone Receptor Complex
12/13/2012CA2838435A1 Derivatives of 1-phenyl-2-pyridinyl alkyl alcohols as phosphodiesterase inhibitors
12/13/2012CA2838194A1 Process for preparing [(3-hydroxypyridine-2-carbonyl)amino]alkanoic acids, esters and amides
12/13/2012CA2837146A1 Benzocycloheptene acetic acids
12/13/2012CA2835745A1 Pyridin - 2 - amides useful as cb2 agonists
12/13/2012CA2833771A1 Compositions and methods for the production of pyrimidine and pyridine compounds with btk inhibitory activity
12/12/2012EP2532653A1 Benzo[1,2,4]triazines as protein kinase modulators
12/12/2012EP2532643A1 IRE-1A Inhibitors
12/12/2012EP2531490A1 Cyclohexyl amide derivatives as crf receptor antagonists
12/12/2012EP2531489A1 Oxalamide derivative as umami flavouring agent
12/12/2012CN102822131A Rare-earth metal complex
12/12/2012CN102816113A Fluoro substituted omega-carboxyaryl diphenyl urea for the treatment and prevention of diseases and conditions
12/12/2012CN102816112A Method for preparing pesticide nitenpyram
1 ... 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 ... 633